Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 10, 2024
Epertinib counteracts multidrug resistance in cancer cells by antagonizing the drug efflux function of ABCB1 and ABCG2Bing-Huan Lin, Yen-Ching Li, Megumi Murakami, et al.
Biochemical Pharmacology|July 8, 2020
Overexpression of ABCB1 and ABCG2 contributes to reduced efficacy of the PI3K/mTOR inhibitor samotolisib (LY3023414) in cancer cell linesChung-Pu Wu, Cheng-Yu Hung, Sabrina Lusvarghi, et al.
Molecular Pharmaceutics|June 10, 2017
Overexpression of ATP-Binding Cassette Subfamily G Member 2 Confers Resistance to Phosphatidylinositol 3-Kinase Inhibitor PF-4989216 in Cancer CellsChung-Pu Wu, Megumi Murakami, Sung-Han Hsiao, et al.
Pharmaceuticals (Basel, Switzerland)|November 25, 2023
Imperatorin Restores Chemosensitivity of Multidrug-Resistant Cancer Cells by Antagonizing ABCG2-Mediated Drug TransportChung-Pu Wu, Megumi Murakami, Yen-Ching Li, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 14, 2026
Lirafugratinib attenuates ABCG2-dependent drug efflux and restores chemosensitivity in multidrug-resistant nonsmall cell lung cancer cellsChung-Pu Wu, Yen-Ching Li, Bing-Huan Lin, et al.
Cancers|January 17, 2020
Sitravatinib Sensitizes ABCB1- and ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic DrugsChung-Pu Wu, Sung-Han Hsiao, Yang-Hui Huang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 9, 2022
The WD repeat-containing protein 5 (WDR5) antagonist WDR5-0103 restores the efficacy of cytotoxic drugs in multidrug-resistant cancer cells overexpressing ABCB1 or ABCG2Chung-Pu Wu, Ya-Ju Hsieh, Han-Yu Tseng, et al.
Plos One|October 3, 2012
Salidroside improves behavioral and histological outcomes and reduces apoptosis via PI3K/Akt signaling after experimental traumatic brain injurySzu-Fu Chen, Hsin-Ju Tsai, Tai-Ho Hung, et al.
Cancer Letters|July 21, 2018
SIS3, a specific inhibitor of Smad3 reverses ABCB1- and ABCG2-mediated multidrug resistance in cancer cell linesChung-Pu Wu, Megumi Murakami, Sung-Han Hsiao, et al.
Cancers|May 14, 2022
P-glycoprotein Mediates Resistance to the Anaplastic Lymphoma Kinase Inhiitor Ensartinib in Cancer CellsChung-Pu Wu, Cheng-Yu Hung, Megumi Murakami, et al.
Pageof 10